Blog Archive

Wednesday, June 22, 2022

06-22-2022-0117 - can exacerbate disease facilitate environment for decay process and minor splitting desynchronization of decay process general. not individual diseases, symptom list, sign list, component nominer, disorders, schizophrenia, genetic disease, etc..

 Gamma-hydroxybutyrate (GHB, also known as sodium oxybate) has been found to be effective at reducing the number of cataplexy episodes.[18][19] Sodium oxybate is generally safe [19] and is typically the recommended treatment.[20]

Sodium oxybate (GHB) is a natural metabolite of GABA. Its main target is the dopaminergic system because at pharmacological concentration it acts as an agonist and modulates the dopamine neurotransmitters and dopaminergic signalling.[17] GHB was used to treat narcolepsy and cataplexy for more than 15 years[4] and it is the only drug authorised by the EMA to treat the whole disease in adults, and by the FDA to treat patients who suffer from cataplexy with the indication to be used for combating excessive daytime sleepiness.[20] This drug helps to normalise the sleep architecture, pushing the REM sleep toward its normal setting, and inhibits the intrusion during the day of its elements like the paralysis in cataplexy.[4]

https://en.wikipedia.org/wiki/Cataplexy


Note. GHB causes serious side effects. do not use glutamine, fat vars, waxes, palming drugs, protein var, antipsychots, steroids, genotox, hormones, waste, CL1 chem vars, etc.. can exacerbate disease facilitate environment for decay process and minor splitting desynchronization of decay process general. not individual diseases, symptom list, sign list, component nominer, disorders, schizophrenia, genetic disease, etc..

https://en.wikipedia.org/wiki/NMDA_receptor_antagonist


No comments:

Post a Comment